Skip to search.
 TSX Down 0.53% TSX Ventures Down 0.63%

More On NRI.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Nuvo Pharmaceuticals Inc. (NRI.TO)

-Toronto
7.25 Down 0.20(2.68%) Sep 26, 3:59PM EDT
Prev Close:7.45
Open:7.48
Bid:7.15
Ask:7.25
1y Target Est:N/A
Beta:-0.393214
Earnings Date:Nov 8 - Nov 14 (Est.)
Day's Range:7.15 - 7.48
52wk Range:3.77 - 8.35
Volume:10,486
Avg Vol (3m):16,265
Market Cap:83.40M
P/E (ttm):1,450.00
EPS (ttm):0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):10.51
P/S (ttm):2.85
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.62
Quarterly EPS Est (Sep-16) :0.17
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nuvo Research Inc. operates as a life sciences company. The company operates through two segments, Nuvo Pharma and Crescita. It offers Pennsaid, a topical non-steroidal anti-inflammatory drug that is used to treat the signs and symptoms of osteoar... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback